The editor in chief of Evidence-Based Oncology, who was recently named medical director of Precision Medicine for The US Oncology Network, discussed milestones met and those still to be achieved.
Commentary|Podcasts|October 3, 2024
Dr Rick Chapman Discusses Key Insights From the Center’s Rare Disease Project
Author(s)Brooke McCormick
On this episode of Managed Care Cast, we're talking with the chief science officer of the Center for Innovation & Value Research about key insights from its Rare Disease project.
Advertisement
Advertisement
On this episode of Managed Care Cast, we're talking with Rick Chapman, PhD, chief science officer of the
Related to this article
Genetic analysis finds 125 loci shared by insomnia and CRP, with Mendelian randomization favoring an effect from insomnia liability to inflammation.
Cleveland roundtable panelists across 4 disease states name access, not evidence, as the shared barrier to care.
Coverage of our peer-reviewed research and news reporting in the health care and mainstream press.
Alice Hall-Partyka, JD, a partner at Crowell & Moring explains the lawsuits challenging CMS' Medicaid rule on pediatric gender care and its legal weak points.
Siva Mohan, MD, explains how drug costs drive silent nonadherence, PA burden, and biosimilar hesitancy, and what payers can do about it.
Proinflammatory diets were tied to higher mortality in MASLD and MetALD, whereas antioxidant-rich diets tracked with better survival.
Inconsistent definitions limit pathological response as a soft tissue sarcoma marker, according to a narrative review.
Advertisement
Advertisement